Former members
- David García Soriano.
- César del Valle.
- Victoria López.
- Dr. Leonor de la Cueva.
- Rebeca Amaro.
- Dr. Yurena Luengo.
- Laura González.
-
Dr. Gorka Salas Hernández
PhD: Universidad de Valladolid, SpainPrevious Position: Laboratoire de Chimie Organometallique de Surface (CNRS), Lyon, FranceResearch: Magnetic NanoparticlesORCID: 0000-0002-1196-8813Researcher ID: F-6503-2011Google Scholar profile: https://scholar.google.es/citations?user=UQ9WA5AAAAAJGroup webpage: Magnetic NanoparticlesJoining Date: January 2011User Name: gorka.salasTelephone: +34 91 299 88 50
Gorka Salas obtained his PhD in Chemistry (2007, University of Valladolid) in the field of organometallic chemistry and homogeneous catalysis. During 2008-2010, he worked at the CNRS (LCC-Toulouse and LCOMS-Lyon), on the synthesis of metal nanoparticles, ionic liquids, and catalytic hydrogenations. He has been at IMDEA Nanociencia since 2011 (including a stay at the ICMM-CSIC, 2011-2013), where his research focuses on the synthesis of magnetic nanoparticles for biomedicine and other applications.
-
Lucía María Pardinas del Águila
Research: Magnetic NanoparticlesGroup webpage: Magnetic NanoparticlesUser Name: lucia.pardinasTelephone: 8837
Lucía Pardinas did her bachelor in Biotechnology and Master in Advanced Therapies and Regenerative Medicine (San Pablo CEU University), with Advance Graduate Certificate in International Business Management (Boston University). Internships at the Gregorio Marañón Hospital (nanotechnology for the control of sexually transmitted viruses) and at IDIPAZ (project for the development of a biomimetic corneal stroma through 3D printing). She is currently a PhD student in the Magnetic Nanoparticles group, at IMDEA Nanociencia, carrying out research in the field of hybrid nanoparticles for biomedical applications.
-
Monica Dhanjani Dhanjani
Research: Magnetic NanoparticlesORCID: 0000-0002-2642-2039Group webpage: Magnetic NanoparticlesJoining Date: March, 2019User Name: monica.dhanjaniTelephone: 8837
Mónica Dhanjani graduated in Chemistry from the Complutense University of Madrid in 2016. During her Master’s degree in Supramolecular Chemistry (Universidad de Salamanca), she did an internship at CICbioMAGUNE (Guipuzkuoa), in the Bionanoplasmonic Group. Since 2019 she has worked in the Magnetic Nanoparticles group at IMDEA Nanociencia, where her research focuses on the synthesis of magnetic nanoparticles for biomedical applications.
-
Denise Maria Cuscela
Research: Magnetic NanoparticlesORCID: https://orcid.org/0009-0006-8732-8528Group webpage: Magnetic NanoparticlesJoining Date: January 2025User Name: denise.cuscela
Denise Maria Cuscela obtained her Bachelor’s degree in Biological Sciences from the University of Bari in 2018. During this period, she gained her first laboratory experience in molecular and cellular biology, acquiring practical skills in techniques such as spectrophotometry, SDS-PAGE, Western blotting, and fluorescence microscopy. Her undergraduate thesis focused on the intestinal transport of amino acids.
In 2019, she joined Janssen Pharmaceutica (Johnson & Johnson, Belgium) as a laboratory technician, where she worked in a GMP environment on the development and validation of Raman spectroscopy-based methods for the identification of raw materials and pharmaceutical products.
Motivated to further specialize in biomedical research, she pursued a Master’s degree in Translational Biomedical Sciences, which she completed in 2024. During her studies, she was awarded an Erasmus+ grant to carry out a research internship at the Complutense University of Madrid. There, she investigated the role of the pseudokinase TRIB3 in prostate cancer progression, using both in vitro (PC3 and DU145 cell lines) and in vivo models. Her work included migration and invasion assays, molecular analyses, and the management and genotyping of genetically modified mouse models.
Since January 2025, she is a PhD researcher at the IMDEA Nanoscience Institute. Her research focuses on the development of nanomedicine-based strategies for the diagnosis and treatment of cancers with limited therapeutic options. In particular, her work involves the design and functionalization of inorganic nanoparticles with nucleic acids, such as aptamers, miRNAs, and antisense oligonucleotides.